Cost-consequence analysis for human recombinant growth hormone (r-hGH) treatment administered via different devices in children with growth hormone deficiency in Italy

Cost-consequence analysis for human recombinant growth hormone (r-hGH) treatment administered via different devices in children with growth hormone deficiency in Italy

Jason Foo,1 Mohamad Maghnie,2 Annamaria Colao,3 Ioanna Vlachaki,4 Giorgio Colombo5,61Global Health Economics, Mapi Group (An ICON plc Company), Houten, The Netherlands; 2Department of Pediatrics, IRCCS Istituto Giannina Gaslini Institute, University of Genova, Genova, Italy; 3Department of Clinical...

Full description

Bibliographic Details
Main Authors: Foo J, Maghnie M, Colao A, Vlachaki I, Colombo G
Format: Article
Language:English
Published: Dove Medical Press 2019-08-01
Series:ClinicoEconomics and Outcomes Research
Subjects:
easypod
growth hormone treatment
growth hormone deficiency
cost-consequence analysis
Online Access:https://www.dovepress.com/cost-consequence-analysis-for-human-recombinant-growth-hormone-r-hgh-t-peer-reviewed-article-CEOR

Internet

https://www.dovepress.com/cost-consequence-analysis-for-human-recombinant-growth-hormone-r-hgh-t-peer-reviewed-article-CEOR

Similar Items